Παρασκευή 31 Μαρτίου 2017

Anticoagulant Reversal and Anesthetic Considerations

alertIcon.gif

Publication date: Available online 30 March 2017
Source:Anesthesiology Clinics
Author(s): Joseph Meltzer, Joseph R. Guenzer

Teaser

Bleeding complications are a common concern with the use of anticoagulant agents. In many situations, reversing of neutralizing their effects may be warranted. Prothrombin complex concentrate replaces coagulation factors lowered by warfarin, as does fresh frozen plasma, but in a more concentrated form. Protamine negates the effect of heparin and combines chemically with heparin molecules to form an inactive salt. It also partially reverses the effects of low-molecular-weight heparin. Recombinant activated factor VII is a nonspecific procoagulant that activates the extrinsic clotting pathway, resulting in thrombin generation, but does not directly neutralize the activity of any of the new oral anticoagulants.


http://ift.tt/2ojrtRQ

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου